Cardiovascular and Limb Outcomes with Tirzepatide versus SGLT2 Inhibitors in Peripheral Artery Disease and Type 2 Diabetes: A Real-world Cohort Study
Michigan Medical Education and Health Bulletin · 29.06.2026 · 4 (2 (supplement))
DOI: 10.69735/001c.163881 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Michigan Medical Education and Health Bulletin, online erschienen am 29.06.2026. Verfasst von Abdul Rasheed Bahar und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bahar, A. R., Bahar, Y., Khoury, I., Raheem, S., & Cardozo, S. (2026). Cardiovascular and Limb Outcomes with Tirzepatide versus SGLT2 Inhibitors in Peripheral Artery Disease and Type 2 Diabetes: A Real-world Cohort Study. Michigan Medical Education and Health Bulletin, 4(2 (supplement)). https://doi.org/10.69735/001c.163881
Vancouver
Bahar AR, Bahar Y, Khoury I, Raheem S, Cardozo S. Cardiovascular and Limb Outcomes with Tirzepatide versus SGLT2 Inhibitors in Peripheral Artery Disease and Type 2 Diabetes: A Real-world Cohort Study. Michigan Medical Education and Health Bulletin. 2026;4(2 (supplement)). doi:10.69735/001c.163881
BibTeX
@article{Bahar2026,
author = {Bahar, Abdul Rasheed and Bahar, Yasemin and Khoury, Ishaq and Raheem, Shaheena and Cardozo, Shaun},
title = {Cardiovascular and Limb Outcomes with Tirzepatide versus SGLT2 Inhibitors in Peripheral Artery Disease and Type 2 Diabetes: A Real-world Cohort Study},
journal = {Michigan Medical Education and Health Bulletin},
year = {2026},
volume = {4},
number = {2 (supplement)},
doi = {10.69735/001c.163881}
}
EUVIMED